151 related articles for article (PubMed ID: 17119063)
1. Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients.
Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2307-10. PubMed ID: 17119063
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer.
Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Scand J Gastroenterol; 2007 May; 42(5):628-32. PubMed ID: 17454884
[TBL] [Abstract][Full Text] [Related]
3. N-acetyltransferase (NAT) 2 acetylator status and age of onset in patients with hereditary nonpolyposis colorectal cancer (HNPCC).
Pistorius S; Görgens H; Krüger S; Engel C; Mangold E; Pagenstecher C; Holinski-Feder E; Moeslein G; von Knebel Doeberitz M; Rüschoff J; Karner-Hanusch J; Saeger HD; Schackert HK;
Cancer Lett; 2006 Sep; 241(1):150-7. PubMed ID: 16337339
[TBL] [Abstract][Full Text] [Related]
4. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset.
Jones JS; Amos CI; Pande M; Gu X; Chen J; Campos IM; Wei Q; Rodriguez-Bigas M; Lynch PM; Frazier ML
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):886-91. PubMed ID: 16702365
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
6. GSTM1 and GSTT1 polymorphisms as modifiers of age at diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) in a homogeneous cohort of individuals carrying a single predisposing mutation.
Felix R; Bodmer W; Fearnhead NS; van der Merwe L; Goldberg P; Ramesar RS
Mutat Res; 2006 Dec; 602(1-2):175-81. PubMed ID: 17087981
[TBL] [Abstract][Full Text] [Related]
7. A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair.
Boardman LA; Schmidt S; Lindor NM; Burgart LJ; Cunningham JM; Price-Troska T; Snow K; Ahlquist DA; Thibodeau SN
Genes Chromosomes Cancer; 2001 Feb; 30(2):181-6. PubMed ID: 11135435
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
[TBL] [Abstract][Full Text] [Related]
9. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees.
Weber TK; Conlon W; Petrelli NJ; Rodriguez-Bigas M; Keitz B; Pazik J; Farrell C; O'Malley L; Oshalim M; Abdo M; Anderson G; Stoler D; Yandell D
Cancer Res; 1997 Sep; 57(17):3798-803. PubMed ID: 9288790
[TBL] [Abstract][Full Text] [Related]
10. The -149C>T SNP within the DeltaDNMT3B gene, is not associated with early disease onset in hereditary non-polyposis colorectal cancer.
Reeves SG; Mossman D; Meldrum CJ; Kurzawski G; Suchy J; Lubinski J; Scott RJ
Cancer Lett; 2008 Jun; 265(1):39-44. PubMed ID: 18336997
[TBL] [Abstract][Full Text] [Related]
11. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
12. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
[TBL] [Abstract][Full Text] [Related]
13. Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53.
Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Int J Cancer; 2006 May; 118(10):2479-84. PubMed ID: 16353134
[TBL] [Abstract][Full Text] [Related]
14. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer.
Miyaki M; Iijima T; Kimura J; Yasuno M; Mori T; Hayashi Y; Koike M; Shitara N; Iwama T; Kuroki T
Cancer Res; 1999 Sep; 59(18):4506-9. PubMed ID: 10493496
[TBL] [Abstract][Full Text] [Related]
15. [Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer].
Fan CH; Jin MJ; Zhang Y; Song L; Xu H; Jiang QT; Yu WP; Chen K
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):13-7. PubMed ID: 16620591
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
[TBL] [Abstract][Full Text] [Related]
17. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.
Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S
Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463
[TBL] [Abstract][Full Text] [Related]
18. Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes.
Frazier ML; O'Donnell FT; Kong S; Gu X; Campos I; Luthra R; Lynch PM; Amos CI
Cancer Res; 2001 Feb; 61(4):1269-71. PubMed ID: 11245417
[TBL] [Abstract][Full Text] [Related]
19. E2F-4 mutation in hereditary non-polyposis colorectal cancer.
Moriyama H; Sasamoto H; Kambara T; Matsubara N; Ikeda M; Baba S; Meltzer SJ; Lynch HT; Shimizu K; Tanaka N
J Exp Clin Cancer Res; 2002 Jun; 21(2):185-9. PubMed ID: 12148576
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome.
Pande M; Amos CI; Osterwisch DR; Chen J; Lynch PM; Broaddus R; Frazier ML
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2393-401. PubMed ID: 18768509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
